2026 NOSCM | Advances in the Treatment of Hormone Receptor Positive Early-stage Breast Cancer: Optimal Sequencing, Use of Targeted Agents
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- Jul 28, 2026
- Last Review
- Jul 28, 2026
- Expires
- Jul 28, 2029
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
Accreditation
N/A
Related Courses
2026 NOSCM | We Should Change Treatment Based on Emerging Mutations in Patients with ER+/HER2- Metastatic Breast Cancer (NO)
0.00 Credits
1 Chapter
Breast
Free
2026 NOSCM | We Should Change Treatment Based on Emerging Mutations in Patients with ER+/HER2- Metastatic Breast Cancer (YES)
0.00 Credits
1 Chapter
Breast
Free